TNFSF13 and breast cancer: Hahne et al [13] reported that APRIL could not elicit any proliferative effect on MCF7 breast cancer cells, in contrast to other cancer cell lines from different tissues, providing a hint for the decreased expression of APRIL in breast tumor specimens, reported here.